3.4094
price up icon4.77%   0.1594
 
loading
Schlusskurs vom Vortag:
$3.25
Offen:
$3.3
24-Stunden-Volumen:
38,096
Relative Volume:
0.58
Marktkapitalisierung:
$100.60M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-35.01M
KGV:
-2.9391
EPS:
-1.16
Netto-Cashflow:
$-24.53M
1W Leistung:
-5.68%
1M Leistung:
-22.96%
6M Leistung:
-45.17%
1J Leistung:
-37.75%
1-Tages-Spanne:
Value
$3.27
$3.47
1-Wochen-Bereich:
Value
$3.22
$3.69
52-Wochen-Spanne:
Value
$3.22
$9.96

Xbiotech Inc Stock (XBIT) Company Profile

Name
Firmenname
Xbiotech Inc
Name
Telefon
512-386-2900
Name
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Name
Mitarbeiter
92
Name
Twitter
@xbiotech_usa
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
XBIT's Discussions on Twitter

Vergleichen Sie XBIT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XBIT
Xbiotech Inc
3.405 100.60M 4.01M -35.01M -24.53M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.71 125.43B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
719.40 76.60B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
670.05 39.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
275.50 35.33B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.28 28.08B 3.30B -501.07M 1.03B -2.1146

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2019-06-14 Eingeleitet Piper Jaffray Overweight
2017-04-21 Herabstufung Noble Financial Buy → Hold
2016-06-28 Bestätigt Noble Financial Buy

Xbiotech Inc Aktie (XBIT) Neueste Nachrichten

pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Feb 04, 2025
pulisher
Jan 30, 2025

XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN

Jan 30, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider

Jan 27, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider

Jan 27, 2025
pulisher
Jan 22, 2025

Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider

Jan 21, 2025
pulisher
Jan 20, 2025

XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - Markets Insider

Jan 20, 2025
pulisher
Jan 18, 2025

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald

Jan 18, 2025
pulisher
Jan 15, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 10, 2025

XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance

Jan 10, 2025
pulisher
Jan 07, 2025

Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks

Dec 31, 2024
pulisher
Dec 31, 2024

Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

XBiotech (NASDAQ:XBIT) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Dec 30, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire

Dec 27, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kzKSPI - PR Newswire

Dec 27, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire

Dec 27, 2024
pulisher
Dec 24, 2024

XBiotech halts all rheumatology research after missing Phase II endpoints - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

Stock market news: YSX Tech. -28.67%, XBiotech -24.76% among biggest losers during mid day trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

Another bump in the road for XBiotech and bermekimab - The Pharma Letter

Dec 23, 2024
pulisher
Dec 23, 2024

Xbiotech Shares Hit 52-Week Low on Halted Rheumatology Program - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Stock Hits 52-Week Low at $3.75 Amid Market Fluctuations - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market today: XBiotech -31.66%, Nvni Group -31.59% among biggest losers in early trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech trading resumes - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Halts Rheumatology Clinical Program - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Pauses Rheumatology program - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Halts Rheumatology Program After Major Data Irregularities Found in Phase 2 Trial - StockTitan

Dec 23, 2024
pulisher
Dec 22, 2024

Fmr LLC Has $224,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

(XBIT) Proactive Strategies - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 16, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 16, 2024
pulisher
Dec 11, 2024

12,157 Shares in XBiotech Inc. (NASDAQ:XBIT) Purchased by MetLife Investment Management LLC - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World

Dec 11, 2024
pulisher
Dec 08, 2024

(XBIT) Investment Analysis and Advice - Stock Traders Daily

Dec 08, 2024
pulisher
Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 30, 2024
pulisher
Nov 28, 2024

Trend Tracker for (XBIT) - Stock Traders Daily

Nov 28, 2024
pulisher
Nov 25, 2024

Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 25, 2024
pulisher
Nov 19, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR

Nov 19, 2024
pulisher
Nov 17, 2024

How To Trade (XBIT) - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

XBiotech: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024

Finanzdaten der Xbiotech Inc-Aktie (XBIT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$80.20
price down icon 0.93%
$20.91
price up icon 1.45%
$356.69
price up icon 1.00%
$5.0799
price down icon 1.38%
biotechnology ONC
$228.63
price up icon 2.49%
$122.55
price up icon 4.61%
Kapitalisierung:     |  Volumen (24h):